COVID-19 Implications for I-O Patient Management

Latest Discussion Posts

  • Purpose: Conversations directly relevant to patient care Audience: Practicing clinicians and staff, clinical investigators Suggested topics: demographics, clinical presentation, diagnostic testing, patient management issues/insights, patterns in ...

    3 people recommend this.
  • The National Cancer Institute (NCI) has released two Request for Applications (RFAs) for components of the new Serological Sciences Network (SeroNet). The two RFAs are for  U01 Research Projects in SARS-CoV-2 Serological Sciences  and  U54 SARS-CoV-2 ...

  • BTK Inhibition for COVID-19 In a prospective, off-label study, the selective Bruton tyrosine kinase inhibitor acalabrutinib was administered off-label to 19 patients hospitalized with severe COVID-19 (11 on supplemental oxygen; 8 on mechanical ventilation). ...

  • Profile Picture

    RE: Shared Resources

    Virtual Symposium Announcement: Cytokines in COVID-19 The NIH/FDA Immunology Interest Group and the NIH/FDA Cytokine Interest Group is holding a seminar on June 18, 2020, 9:00am - 1:45pm ET. Topics will include the dynamic cytokine response over the ...

  • Results from Italian TOCIVID-19 clinical trial of tocilizumab Finally we have data from TOCIVID-19 clinical trial about tocilizumab use. Analysis on 301 patients enrolled for the phase 2 study (in only 20 hours between March 19 and 20) and 920 patients ...


  • Using this discussion board

    If you are not already logged in to the SITC website, you will come to a login page. Enter your username and password. (This process is the same for Members and Non-members).

    If you don’t remember your username or password, click the reset password link. This will send you an email to the email address that SITC has on file.

    If you don’t have a SITC account, click the link to create a free CONNECT account. You do not need to become a member to participate in the discussions.

    Click “Post New Message” or reply to an existing discussion.

    Select how often you would like to receive email messages about this discussion or opt out of email updates.

    Type your message and click “Send.”

    This discussion board is devoted to conversations directly relevant to clinical care. Example topics include:

    • Trends in demographics
    • Trends in clinical presentation
    • Issues regarding diagnostic testing
    • Patient management issues/insights
    • Observations on emerging natural history/patterns in clinical complications
    • Difficult cases

    This forum contains several discussion threads that were started to help organize the information and allow users to quickly find relevant conversations. These topics are not meant to be comprehensive or limiting and new threads as well as additional related questions within existing conversations are welcomed.

    Posts flagged as inappropriate will be moderated by SITC. The forums are not intended to distract from or replace guidance and rules communicated by federal, state and local health authorities, including the Centers for Disease Control and Prevention (CDC). Thus, it is important that we all work together, and that participants be responsible, use good judgement, and follow established rules for integrity and patient confidentiality without exception. Please be respectful and limit posts to information that is directly relevant to the topics being discussed.

    A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies or courses of action discussed here.